Skip Ribbon Commands
Skip to main content



Primary Diagnosis

All Adults on Aspirin

Stu​dy Purpose

The purpose of this study is to determine the optimal dose of aspirin for secondary prevention in patients with ASCVD.

Principal Investigator: Peter McCullough, MD

Trial Details

Locations: Legacy Heart Center, Baylor Scott & White Heart and Vascular Hospital

Sponsor: Duke University

IRB Number: 016-067

Trial Status: Enrolling

Exclusions: Adults only

Change in Care: Participating will not change your care

Contact Information:

Call 469.814.4720

Full Protocol Title

Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)

Get Detailed Information On »​​​​​​​​​​​​​​​​​